All Type of News
Backlash to massive drug price slash for items on appeal.
The drug industry sharply resists against the government's massive price slashes particularly for the items that earlier raised appeals, claiming that the government decision was measured without paying any considerat...
Seoul Court of Administration Throws Out Case Filed by Choseun Pharmaceutical Corp.
The Seoul Court of Administration issued a final judgment on September 13 throwing out the appeal filed by Choseun Pharmaceutical Corp. in connection with the administrative measure made against it by the Korea Food &...
Zuellig issue likely to sort out in Sept.
The Zuellig issue seems to be resolved very soon, judging by the fact that the Struggle Committee for Zuellig Issue ultimately asked Zuellig for the business terms and conditions instead of number of business associat...
Law on Oriental Medicine Management Goes Against Medical Unification
The Ministry of Health and Welfare is considering whether to implement a law on Oriental medicine management to promote the development of the Oriental medicine industry in the country.
Amid growing opposition f...
Pharmaceutical Companies Under Obligation to Report in Advance for Supporting Society
Pharmaceutical companies should report the purpose, schedule, location and the number of participants 10 days in advance to the Korea Fair Competition Bureau to support the society, and strong measures will be taken s...
Submission of Prescription List to Be Decided soon
The Korean Medical Association (KMA) is expected to make a decision by September 15 whether to submit a prescription list of ordinary medical supplies or suspend it further.
This is because the Ministry of Health...
Ildong Pharmaceutical Company Exits From Workout Program After 34 Months
Ildong Pharmaceutical Company has gotten out of the workout program 34 months after it was placed under the program by the Korea Development Bank (KDB) in December 1998.
According to the KDB a documentary resolu...
Common prescription drug list prescribed in law turned useless.
The regulation pertaining to the Common Prescription Drug List as prescribed in the Pharmaceutical Affair Act revised in August this year seems to be remained only in paper without any provisional effects because of n...
KFDA instructed label change over 91 products including Ranitidine.
The KFDA instructed to revised direction circulars for 91 drugs, additionally inserting new adverse reactions including H2 receptor blocker such as Ranitidine.
The informations about such drug adverse reactions hav...
Bio Venture Firm Crosses Great Wall of ChinaA bio venture firm has successfully crossed the Great Wall of China.
Biopharm, which develops an oral type of gastritis vaccine, signed a general marketing cooperation agr...
|
